Patents by Inventor Kristen M.S. O'Connell

Kristen M.S. O'Connell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TRPC3 AS A THERAPEUTIC TARGET FOR ALZHEIMER’S DISEASE
    Publication number: 20240099277
    Abstract: Provided herein, in some embodiments, are methods for modulating expression and/or activity of transient receptor potential cation channel subfamily C, member 3 (TRPC3), as well as methods of treating Alzheimer's disease.
    Type: Application
    Filed: June 15, 2023
    Publication date: March 28, 2024
    Applicant: The Jackson Laboratory
    Inventors: Catherine Kaczorowski, Sarah M. Neuner, Kristen M.S. O'Connell
  • TRPC3 as a therapeutic target for alzheimer's disease
    Patent number: 11723347
    Abstract: Provided herein, in some embodiments, are methods for modulating expression and/or activity of transient receptor potential cation channel subfamily C, member 3 (TRPC3), as well as methods of treating Alzheimer's disease.
    Type: Grant
    Filed: November 19, 2019
    Date of Patent: August 15, 2023
    Assignee: The Jackson Laboratory
    Inventors: Catherine Kaczorowski, Sarah M. Neuner, Kristen M. S. O'Connell
  • TRPC3 AS A THERAPEUTIC TARGET FOR ALZHEIMER'S DISEASE
    Publication number: 20200154683
    Abstract: Provided herein, in some embodiments, are methods for modulating expression and/or activity of transient receptor potential cation channel subfamily C, member 3 (TRPC3), as well as methods of treating Alzheimer's disease.
    Type: Application
    Filed: November 19, 2019
    Publication date: May 21, 2020
    Applicant: The Jackson Laboratory
    Inventors: Catherine Kaczorowski, Sarah M. Neuner, Kristen M.S. O'Connell